Orchard Therapeutics Income Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2021
Period Ending	Jun '25 Jun 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2021
Operating Revenue	3,035	2,943	3,315	2,926	2,344	1,735	Upgrade
Other Revenue	-1.59	2.85	2.22	7.24	5.28	4.13	Upgrade
Revenue	3,033	2,946	3,317	2,933	2,349	1,740	Upgrade
Revenue Growth (YoY)	-10.46%	-11.20%	13.09%	24.86%	35.05%	172.88%	Upgrade
Cost of Revenue	2,179	2,140	2,202	2,029	1,671	1,259	Upgrade
Gross Profit	854.68	805.35	1,115	904.28	678.36	480.82	Upgrade
Selling, General & Admin	42.64	42.64	19.47	16.06	24.77	22.93	Upgrade
Other Operating Expenses	480.91	449.19	362.22	302.4	264.29	237.52	Upgrade
Operating Expenses	683.35	642.97	552.51	465.73	446.51	412	Upgrade
Operating Income	171.33	162.38	562.6	438.55	231.85	68.82	Upgrade
Interest Expense	-28.19	-24.35	-58.78	-59.04	-60.18	-86.14	Upgrade
Interest & Investment Income	104.38	104.38	20.05	42.36	67.44	66.87	Upgrade
Currency Exchange Gain (Loss)	2.33	2.33	1.76	4.56	4.05	2.02	Upgrade
Other Non Operating Income (Expenses)	1.12	1.12	0.51	1.05	2.2	-7.56	Upgrade
EBT Excluding Unusual Items	250.96	245.86	526.13	427.48	245.36	44.01	Upgrade
Gain (Loss) on Sale of Investments	0.61	0.61	1.44	0.73	0.03	1.64	Upgrade
Gain (Loss) on Sale of Assets	0.65	0.65	7.28	1.35	1.98	0.01	Upgrade
Asset Writedown	-	-	-	-3.76	-0.43	-	Upgrade
Other Unusual Items	0.57	0.57	0.85	0.02	0.06	1.1	Upgrade
Pretax Income	252.79	247.68	535.69	425.82	247	46.76	Upgrade
Income Tax Expense	59.23	61.08	138.44	113.22	54.45	15.99	Upgrade
Net Income	193.56	186.6	397.25	312.6	192.55	30.77	Upgrade
Net Income to Common	193.56	186.6	397.25	312.6	192.55	30.77	Upgrade
Net Income Growth	-53.23%	-53.03%	27.08%	62.35%	525.77%	340.72%	Upgrade
Shares Outstanding (Basic)	50	50	45	44	44	44	Upgrade
Shares Outstanding (Diluted)	50	50	45	44	44	44	Upgrade
Shares Change (YoY)	8.19%	12.58%	0.85%	-0.01%	-	8.97%	Upgrade
EPS (Basic)	3.84	3.70	8.86	7.03	4.33	0.69	Upgrade
EPS (Diluted)	3.84	3.70	8.86	7.03	4.33	0.69	Upgrade
EPS Growth	-56.77%	-58.28%	26.03%	62.36%	527.54%	303.51%	Upgrade
Free Cash Flow	-	-198.27	93.94	243.13	604.53	489.29	Upgrade
Free Cash Flow Per Share	-	-3.93	2.10	5.47	13.60	11.01	Upgrade
Dividend Per Share	-	1.500	2.000	0.400	0.500	0.400	Upgrade
Dividend Growth	-	-25.00%	400.00%	-20.00%	25.00%	247.83%	Upgrade
Gross Margin	28.18%	27.34%	33.61%	30.83%	28.87%	27.64%	Upgrade
Operating Margin	5.65%	5.51%	16.96%	14.95%	9.87%	3.96%	Upgrade
Profit Margin	6.38%	6.33%	11.97%	10.66%	8.20%	1.77%	Upgrade
Free Cash Flow Margin	-	-6.73%	2.83%	8.29%	25.73%	28.13%	Upgrade
EBITDA	200.68	190.5	585.79	460.29	253.37	96.73	Upgrade
EBITDA Margin	6.62%	6.47%	17.66%	15.69%	10.78%	5.56%	Upgrade
D&A For EBITDA	29.36	28.13	23.19	21.74	21.52	27.91	Upgrade
EBIT	171.33	162.38	562.6	438.55	231.85	68.82	Upgrade
EBIT Margin	5.65%	5.51%	16.96%	14.95%	9.87%	3.96%	Upgrade
Effective Tax Rate	23.43%	24.66%	25.84%	26.59%	22.05%	34.20%	Upgrade
Revenue as Reported	3,149	3,062	3,354	3,000	2,450	1,832	Upgrade
Advertising Expenses	-	6.27	8.41	6.71	5.14	3.69	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.